Telix Pharmaceuticals Limited (TLX)

11.94USD +1.70% (+0.20)

Over 1M: +3.6%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

11 11.5 12 12.5
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
FY23 — Revenue: 333M FY23 — Operating Income: 11M FY24 — Revenue: 516.6M FY24 — Operating Income: 55.2M FY25 — Revenue: 803.8M FY25 — Operating Income: 29.8M 0 200M 400M 600M 800M 1B
FY23 FY24 FY25
Revenue Operating Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.0
ROIC 3.1%
OE margin -7.7%
Accruals 0.87%
Gross margin 53.1%
Profit margin -0.89%
ROA -0.61%
ROCE 3.2%
ROE -1.7%
FCF margin -5.3%
OCF / EBIT -0.58×
OCF margin -2.2%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/EBIT 282.2×
EV/OE -135.3×
EV/GP 19.7×
EV/Sales 10.5×
FCF yield -0.53%
P/B 19.4×
P/C 56.8×
Div. yield —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.0
Segment HHI 0.64 HHI
RPO / sales —
RPO growth —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.1
Interest cover 164.5×
ND/EBITDA -0.04
Cash / Debt 0.3×
Quick ratio 1.3×
Debt / Eq 1.2×
Net debt / Eq 0.81×
F-score 3.0 pts
Cash runway —
Debt payback —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.1
Sales/sh Y/Y +59.0%
EBIT CAGR +64.4%
EBIT Y/Y -46.0%
EPS Y/Y -121.6%
Div. growth —
EPS CAGR 4Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.